BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 31589773)

  • 1. Pembrolizumab-induced pseudoepitheliomatous eruption consistent with hypertrophic lichen planus.
    Coscarart A; Martel J; Lee MP; Wang AR
    J Cutan Pathol; 2020 Mar; 47(3):275-279. PubMed ID: 31589773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nivolumab-induced lichen planus pemphigoides.
    Strickley JD; Vence LM; Burton SK; Callen JP
    Cutis; 2019 Apr; 103(4):224-226. PubMed ID: 31116807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertrophic lichen planus-like reactions combined with infundibulocystic hyperplasia: pathway to neoplasia.
    Kossard S; Thompson C; Duncan GM
    Arch Dermatol; 2004 Oct; 140(10):1262-7. PubMed ID: 15492191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertrophic lichenoid dermatitis immune-related adverse event during combined immune checkpoint and exportin inhibitor therapy: A diagnostic pitfall for superficially invasive squamous cell carcinoma.
    Marques-Piubelli ML; Tetzlaff MT; Nagarajan P; Duke TC; Glitza Oliva IC; Ledesma DA; Aung PP; Torres-Cabala CA; Wistuba II; Prieto VG; Nelson KC; Curry JL
    J Cutan Pathol; 2020 Oct; 47(10):954-959. PubMed ID: 32394425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffuse lichen planus-like keratoses and clinical pseudo-progression associated with avelumab treatment for Merkel cell carcinoma, a case report.
    Cardis MA; Jiang H; Strauss J; Gulley JL; Brownell I
    BMC Cancer; 2019 Jun; 19(1):539. PubMed ID: 31164102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disseminated erythema with intense and selective inflammation of sweat gland and lichenoid drug eruption during nivolumab therapy.
    Matsumoto Y; Kadono T; Matsuoka M; Kawakami T; Furuya N; Doi M; Hoshikawa M; Soma Y
    J Dermatol; 2018 Feb; 45(2):e33-e34. PubMed ID: 28984022
    [No Abstract]   [Full Text] [Related]  

  • 7. Hypertrophic lichen planus mimicking squamous cell carcinoma.
    Tan E; Malik R; Quirk CJ
    Australas J Dermatol; 1998 Feb; 39(1):45-7. PubMed ID: 9529690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lichenoid Dermatologic Toxicity From Immune Checkpoint Blockade Therapy: A Detailed Examination of the Clinicopathologic Features.
    Tetzlaff MT; Nagarajan P; Chon S; Huen A; Diab A; Omar P; Aung PP; Torres-Cabala CA; Mays SR; Prieto VG; Curry JL
    Am J Dermatopathol; 2017 Feb; 39(2):121-129. PubMed ID: 28134729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lichen planus in a patient treated with pembrolizumab for metastatic malignant melanoma.
    Denny J; Chong H; Akhras V
    Clin Exp Dermatol; 2018 Apr; 43(3):354-356. PubMed ID: 29222829
    [No Abstract]   [Full Text] [Related]  

  • 10. Nivolumab-induced lichenoid penile ulceration and re-emergent mucocutaneous eruption treated with hydroxychloroquine.
    Headd VA; Mathien A; Pei S; Kuraitis D
    Australas J Dermatol; 2024 Jun; 65(4):e97-e99. PubMed ID: 38337182
    [No Abstract]   [Full Text] [Related]  

  • 11. Eruptive Keratoacanthomas Associated With Pembrolizumab Therapy.
    Freites-Martinez A; Kwong BY; Rieger KE; Coit DG; Colevas AD; Lacouture ME
    JAMA Dermatol; 2017 Jul; 153(7):694-697. PubMed ID: 28467522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bullous lichen planus and anti-programmed cell death-1 therapy: Case report and literature review.
    de Lorenzi C; André R; Vuilleumier A; Kaya G; Abosaleh M
    Ann Dermatol Venereol; 2020 Mar; 147(3):221-227. PubMed ID: 31982173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digital ulcerative lichenoid dermatitis in a patient receiving anti-PD-1 therapy.
    Martínez-Doménech Á; García-Legaz Martínez M; Magdaleno-Tapial J; Valenzuela-Oñate C; Pérez-Pastor G; Pérez-Ferriols A
    Dermatol Online J; 2019 Sep; 25(9):. PubMed ID: 31738845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intralymphatic histiocytosis in a patient with lung adenocarcinoma treated with pembrolizumab: a case report.
    Sugano T; Seike M; Funasaka Y; Yoshida M; Takayama R; Okamura K; Nakanishi A; Tanaka T; Takeuchi S; Noro R; Minegishi Y; Kubota K; Saeki H; Gemma A
    J Immunother Cancer; 2019 Feb; 7(1):59. PubMed ID: 30813943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Squamous cell carcinoma complicating lichen planus: a clinico-pathological study of three cases.
    Gawkrodger DJ; Stephenson TJ; Thomas SE
    Dermatology; 1994; 188(1):36-9. PubMed ID: 8305755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of lichenoid drug eruption associated with sildenafil citratus.
    Antiga E; Melani L; Cardinali C; Giomi B; Caproni M; Francalanci S; Fabbri P
    J Dermatol; 2005 Dec; 32(12):972-5. PubMed ID: 16471460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lichenoid drug eruption after treatment with ixekizumab for plaque psoriasis.
    Ghiam N; Ojong O; Vasile G; Romanelli P; Kerdel F
    Dermatol Online J; 2020 Dec; 26(12):. PubMed ID: 33423430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple erosive lichen planus preceded by solitary lichen planus after combination therapy with nivolumab and radiation.
    Komori T; Honda T; Irie H; Otsuka A; Kabashima K
    J Eur Acad Dermatol Venereol; 2017 Aug; 31(8):e382-e384. PubMed ID: 28295693
    [No Abstract]   [Full Text] [Related]  

  • 19. Case Report of Multiple Keratoacanthomas and Squamous Cell Carcinomas in a Patient Receiving Pembrolizumab.
    Chaudhari S; Leon A; Levin E; Neuhaus I; Liao W
    J Drugs Dermatol; 2017 May; 16(5):513-515. PubMed ID: 28628690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lichen planus-like drug eruptions due to β-blockers: a case report and literature review.
    Fessa C; Lim P; Kossard S; Richards S; Peñas PF
    Am J Clin Dermatol; 2012 Dec; 13(6):417-21. PubMed ID: 22809321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.